Exome Sequencing to Predict Neoantigens in Melanoma.

Exome Sequencing to Predict Neoantigens in Melanoma.

Item
http://www.wikidata.org/entity/Q40864095
Twelve-year survival and immune correlates in dendritic cell-vaccinated melanoma patients.Prediction and prioritization of neoantigens: integration of RNA sequencing data with whole-exome sequencing.Use of HLA peptidomics and whole exome sequencing to identify human immunogenic neo-antigens.Precision medicine driven by cancer systems biology.The future of immunotherapy for sarcoma.Combination strategies to enhance the potency of monocyte-derived dendritic cell-based cancer vaccines.Peptide vaccines in cancer-old concept revisited.Selection of Shared and Neoantigen-Reactive T Cells for Adoptive Cell Therapy Based on CD137 Separation.CIMT 2016: Mechanisms of efficacy in cancer immunotherapy - Report on the 14th Annual Meeting of the Association for Cancer Immunotherapy May 10-12 2016, Mainz, Germany.Hitting the Target: How T Cells Detect and Eliminate Tumors.Recent Advances in Targeting CD8 T-Cell Immunity for More Effective Cancer Immunotherapy.Targeting Neoantigens in Glioblastoma: An Overview of Cancer Immunogenomics and Translational Implications.Pan-cancer analysis of neoepitopes
P2860

Exome Sequencing to Predict Neoantigens in Melanoma.

Item
http://www.wikidata.org/entity/Q40864095
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Exome Sequencing to Predict Neoantigens in Melanoma.
@en
type
label
Exome Sequencing to Predict Neoantigens in Melanoma.
@en
prefLabel
Exome Sequencing to Predict Neoantigens in Melanoma.
@en
P1433
P1476
P2093
P304
P31
P356
P433
P478
P50
P577
P698
P356
P1433
P1476
Exome Sequencing to Predict Neoantigens in Melanoma
@en
P2093
P304
P31
P356
10.1158/2326-6066.CIR-15-0088
P433
P478
P50
P577
P698